Get started
Author

Fruzsina Kiss

Observed name: Kiss, Fruzsina
ORCID: 0000-0001-9020-1567
Observed ORCID: 0000-0001-9020-1567
OpenAlex ID: A5028274139
Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients
2022 · Lilla Tóth, Márk F. Juhász, et al. · International Journal of Molecular Sciences · 53
PDF
Functional Transient Receptor Potential Ankyrin 1 and Vanilloid 1 Ion Channels Are Overexpressed in Human Oral Squamous Cell Carcinoma
2022 · Fruzsina Kiss, Viktória Kormos, et al. · International Journal of Molecular Sciences · 34
PDF
Transient Receptor Potential (TRP) Channels in Head-and-Neck Squamous Cell Carcinomas: Diagnostic, Prognostic, and Therapeutic Potentials
2020 · Fruzsina Kiss, Krisztina Pohóczky, et al. · International Journal of Molecular Sciences · 28
PDF
Addition of epidermal growth factor receptor inhibitors to standard chemotherapy increases survival of advanced head and neck squamous cell carcinoma patients: A systematic review and meta‐analysis
2022 · Fruzsina Kiss, Krisztina Pohóczky, et al. · Oral Diseases · 8
PDF
Tourism of South Korea - In a Hungarian perception
2023 · Kiss, Fruzsina · University of Debrecen Electronic Archive (University of Debrecen)
Author response for "Addition of epidermal growth factor receptor inhibitors to standard chemotherapy increases survival of advanced head and neck squamous cell carcinoma patients: A systematic review and meta-analysis"
2022 · Kiss, Fruzsina, Pohoczky, Krisztina, et al. · Publons reviews and discussion
Fej-nyak régió primer melanomája: irodalmi összefoglaló és öt eset ismertetése
2017 · Fruzsina Kiss, Gábor Fülöp, et al. · Fogorvosi Szemle
PDF
Works count: 7
Citation count: 123
H-index: 4
I10-index: 3
Year
Topic
Type